Literature DB >> 11291240

Cholestasis and alcoholic liver disease.

B Y Tung1, R L Carithers.   

Abstract

Histologic cholestasis and clinical jaundice may be seen in all stages of alcoholic liver disease. In rare cases, isolated cholestasis without significant steatosis, hepatitis, or cirrhosis is identified in an alcoholic patient. The mechanisms of ethanol-induced cholestasis are not well studied but may involve compression of intrahepatic biliary radicals or interference with basolateral uptake and intracellular transport of bile acids. In the evaluation of the jaundiced alcoholic patient, clinical, biochemical, and radiologic data are usually sufficient to distinguish alcohol-induced liver disease from extrahepatic biliary obstruction. In cases where the diagnosis is not readily apparent, more invasive studies such as liver biopsy or ERCP may be necessary. The risk of these invasive studies is directly related to the degree of underlying hepatic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11291240     DOI: 10.1016/s1089-3261(05)70086-6

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  15 in total

1.  Are liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomy.

Authors:  Per Videhult; Gabriel Sandblom; Claes Rudberg; Ib Christian Rasmussen
Journal:  HPB (Oxford)       Date:  2011-05-11       Impact factor: 3.647

Review 2.  Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury.

Authors:  Min You; Zhou Zhou; Michael Daniels; Alvin Jogasuria
Journal:  Gene Expr       Date:  2017-11-02

3.  A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease.

Authors:  P Sorrentino; G Tarantino; A Perrella; P Micheli; O Perrella; P Conca
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

4.  Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.

Authors:  Heng-Hong Li; John B Tyburski; Yi-Wen Wang; Steve Strawn; Bo-Hyun Moon; Bhaskar V S Kallakury; Frank J Gonzalez; Albert J Fornace
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

5.  Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae.

Authors:  Deanna L Howarth; Chunyue Yin; Karen Yeh; Kirsten C Sadler
Journal:  Zebrafish       Date:  2013-05-22       Impact factor: 1.985

6.  Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.

Authors:  Laurent Spahr; Laura Rubbia-Brandt; Muriel Genevay; Antoine Hadengue; Emiliano Giostra
Journal:  BMC Gastroenterol       Date:  2011-10-28       Impact factor: 3.067

Review 7.  Pathology of Alcoholic Liver Disease.

Authors:  Romulo Celli; Xuchen Zhang
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

Review 8.  Meta-Analysis and Systematic Review of Primary Renal Tubular Acidosis in Patients With Autoimmune Hepatitis and Alcoholic Hepatitis.

Authors:  Eyad Gadour; Tamer Mohamed; Zeinab Hassan; Abdalla Hassan
Journal:  Cureus       Date:  2021-05-28

Review 9.  Ethanol: striking the cardiovascular system by harming the gut microbiota.

Authors:  Carla B P Silva; Jefferson Elias-Oliveira; Cameron G McCarthy; Camilla F Wenceslau; Daniela Carlos; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-18       Impact factor: 5.125

Review 10.  Role of farnesoid X receptor and bile acids in alcoholic liver disease.

Authors:  Sharon Manley; Wenxing Ding
Journal:  Acta Pharm Sin B       Date:  2015-03-09       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.